| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Self Improvement > Inspirational > Death Wish |
|
E-Articles - Death Wish
I tremble at the thought that millions of people suffer enough to entertain a death wish. Perhaps it is as common a component of the p According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product syche as suffering is a widespread phenomenon among humans. I suppose it is normally counterbalanced by the appetite for life, which j ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in y and hope can whet, but is it ever overturned? Probably not, at least not for long, and that worries me. Could numerous instances of lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ig-risk-taking be death-wish-related? Overeating, smoking, speeding, every human deed that is potentially lethal, including war, may b here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe symptomatic of a death wish, all the more pernicious as it is usually denied or concealed behind other motives. Why do people insist d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro on denying or concealing it? Because they are rightfully ashamed of it! Think of the insanity: Without their knowing and approving it, ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc their death wish may harm them and aggravate their suffering, in which case it would intensify, then probably harm them again and aggr easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi vate their suffering, and so on and so forth until it destroyed them. Is it not imperative that they break out of this vicious circle? nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically Should they not humbly recognize their self-destructive weakness in the face of suffering? Should they not fight this weakness with ev and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ry bit of strength they can gather, in the name of all the things that matter to them? May they spare themselves the shame of wreckin ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi the very life that makes all these things possible, not by a devious means that disguises a self-inflicted tragedy as a cruel twist o ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a f fate, but through their courageous and generous effort to live and love in spite of difficulties! As the particular individuals they dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod are, their existence is their one and only opportunity to experience and contemplate the awesome and fleeting beauty of the world, and cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin prove worthy. May they grasp this opportunity before it slips away from them! They will die soon enough. Some of them may disagree. I tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen know how disgusted with life and tempted by death one can be. This knowledge almost killed me. I also know one can learn to love life t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel nd commit oneself to it. This second knowledge reveals the nature of the first one, which is in fact a state of ignorance and foolishn ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ss. I speak from experience and endorse this proverb: Every cloud has a silver lining. Misery contains a possibility of happiness. Al y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ow me to qualify this statement. Life is rarely desperate. One can usually bring about the changes that are favorable to contentment, . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de f one strives for them. These changes may concern mostly one’s attitude toward a difficult situation that is largely unchangeable. A s elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ile is a sunlike wonder reminiscent of a dandelion that can blossom and multiply on practically barren ground despite countless rigors tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Step SIX of Buying Profitable Single Family Houses
|